More pediatric deaths have happened in 2025 than any other year since 2009, reflecting a drop in childhood vaccination rates.

The HHS will require all new vaccines to undergo placebo-controlled trials, likely slowing down approvals and decreasing access.

The prevalence of mental health and neurodevelopmental disorder diagnoses has increased among children since 2010.

Adding perioperative pembrolizumab to standard care can improve EFS in locally advanced head and neck cancer, data suggest.

The FDA has approved Selarsdi (ustekinumab-aken) as interchangeable to the reference product Stelara (ustekinumab).

The HIV-1 trimer vaccine induced mild-to-moderate adverse effects, exhibiting a similar safety profile to other approved mRNA vaccines.

The use of HMME-PDT is associated with a positive response and is well-tolerated among patients with facial port-wine stains.

Daily oral immunotherapy with peanut protein significantly increased tolerance in the majority of adults with allergy.

Physical exercise reduced psychological, cardiological, and neurological adverse effects in people with cancer.

The majority of patients with advanced melanoma who stop treatment with immune checkpoint inhibitor therapies remain relapse-free.

Power outages longer than four hours, especially large-scale ones, increased the risk for pediatric carbon monoxide poisoning.

Prefrontal-cerebellar transcranial pulsed current stimulation significantly improved social functioning and sleep scores over 4 weeks.